Sandbox Reserved 1110
From Proteopedia
(Difference between revisions)
(One intermediate revision not shown.) | |||
Line 15: | Line 15: | ||
Residue Count: '''236''' | Residue Count: '''236''' | ||
- | 5LSD is the recombinant mouse '''Nerve Growth Factor (NGF)''', that does not bind to '''any ligand'''. Therefore it allows conclusions on the features of its binding loops, i.e. the NGF N-Terminus structure in absence of ligands. Further, the flexibility of the loops can be targeted through 5LSD as well as their impact on the overall structural plasticity of mature NGF. 5LSD also clarifies about the loops´ contribution to antibody recognition. | + | 5LSD is the recombinant mouse '''Nerve Growth Factor (NGF)''', that does not bind to '''any ligand'''. Therefore it allows conclusions on the features of its binding loops, i.e. the NGF N-Terminus structure in absence of ligands. Further, the flexibility of the loops can be targeted through 5LSD as well as their impact on the overall structural plasticity of mature NGF. 5LSD also clarifies about the loops´ contribution to antibody recognition. <ref>PMID: 28083536</ref> |
- | |||
== Structure == | == Structure == | ||
Line 31: | Line 30: | ||
The members of the neurotrophin family are then as useful in prenatal organisms for the development of cortexes and in adulthood, where they control synaptic function and plasticity and sustain neuronal cell survival. | The members of the neurotrophin family are then as useful in prenatal organisms for the development of cortexes and in adulthood, where they control synaptic function and plasticity and sustain neuronal cell survival. | ||
- | == | + | == Diseases and use in Biotechnologies/ Relevance == |
As NGF is the prototype of the neurotrophin family, a better understanding of NGF could lead to a better understanding of the whole family. A better knowledge of NGF, i.e. through 5LSD, is supportive. | As NGF is the prototype of the neurotrophin family, a better understanding of NGF could lead to a better understanding of the whole family. A better knowledge of NGF, i.e. through 5LSD, is supportive. |
Current revision
This Sandbox is Reserved from 25/11/2019, through 30/9/2020 for use in the course "Structural Biology" taught by Bruno Kieffer at the University of Strasbourg, ESBS. This reservation includes Sandbox Reserved 1091 through Sandbox Reserved 1115. |
To get started:
More help: Help:Editing |
5LSD
|
References
- ↑ Paoletti F, de Chiara C, Kelly G, Covaceuszach S, Malerba F, Yan R, Lamba D, Cattaneo A, Pastore A. Conformational Rigidity within Plasticity Promotes Differential Target Recognition of Nerve Growth Factor. Front Mol Biosci. 2016 Dec 26;3:83. doi: 10.3389/fmolb.2016.00083. eCollection, 2016. PMID:28083536 doi:http://dx.doi.org/10.3389/fmolb.2016.00083
- ↑ Paoletti F, de Chiara C, Kelly G, Covaceuszach S, Malerba F, Yan R, Lamba D, Cattaneo A, Pastore A. Conformational Rigidity within Plasticity Promotes Differential Target Recognition of Nerve Growth Factor. Front Mol Biosci. 2016 Dec 26;3:83. doi: 10.3389/fmolb.2016.00083. eCollection, 2016. PMID:28083536 doi:http://dx.doi.org/10.3389/fmolb.2016.00083
- ↑ Tiveron C, Fasulo L, Capsoni S, Malerba F, Marinelli S, Paoletti F, Piccinin S, Scardigli R, Amato G, Brandi R, Capelli P, D'Aguanno S, Florenzano F, La Regina F, Lecci A, Manca A, Meli G, Pistillo L, Berretta N, Nistico R, Pavone F, Cattaneo A. ProNGF\NGF imbalance triggers learning and memory deficits, neurodegeneration and spontaneous epileptic-like discharges in transgenic mice. Cell Death Differ. 2013 Aug;20(8):1017-30. doi: 10.1038/cdd.2013.22. Epub 2013, Mar 29. PMID:23538417 doi:http://dx.doi.org/10.1038/cdd.2013.22
- ↑ Bannwarth B, Kostine M. Targeting nerve growth factor (NGF) for pain management: what does the future hold for NGF antagonists? Drugs. 2014 Apr;74(6):619-26. doi: 10.1007/s40265-014-0208-6. PMID:24691709 doi:http://dx.doi.org/10.1007/s40265-014-0208-6
- ↑ Bannwarth B, Kostine M. Targeting nerve growth factor (NGF) for pain management: what does the future hold for NGF antagonists? Drugs. 2014 Apr;74(6):619-26. doi: 10.1007/s40265-014-0208-6. PMID:24691709 doi:http://dx.doi.org/10.1007/s40265-014-0208-6